Cabozantinib-induced renal thrombotic microangiopathy
- PMID: 29250919
- PMCID: PMC6084320
- DOI: 10.1111/nep.13086
Cabozantinib-induced renal thrombotic microangiopathy
Figures

References
-
- Koopman T, Niedlich‐den Herder C, Stegeman CA et al. Kidney involvement in systemic calcitonin amyloidosis associated with medullary thyroid carcinoma. Am. J. Kidney Dis. 2017; 69: 546–9. - PubMed
-
- Hoy SM. Cabozantinib: a review of its use in patients with medullary thyroid cancer. Drugs 2014; 74: 1435–44. - PubMed
-
- Merza H, Bilusic M. Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions. Curr. Oncol. Rep. 2017; 19: 27. - PubMed
-
- Brunocilla E, Borghesi M, Schiavina R et al. Small renal masses initially managed using active surveillance: results froma a retrospective study with long term follow up. Clin. Genitourin. Cancer 2014; 12: 178–81. - PubMed
-
- Ollero M, Sahali D. Inhibition of the VEGF signalling pathway and glomerular disorders. Nephrol. Dial. Transplant. 2015; 30: 1449–55. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical